メニュー 戻るLS53 Application of RWD to Clinical Development: Discussion with Industry, Regulatory, and Academia Through Hypothetical Case Studies

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS53 Application of RWD to Clinical Development: Discussion with Industry, Regulatory, and Academia Through Hypothetical Case Studies

Session Chair(s)

Takashi  Moriya, PhD, MBA

Takashi Moriya, PhD, MBA

  • Product Owner (Senior Manager) - Healthcare
  • Woven Alpha, Inc. (Woven Planet Holdings, Inc. group company), Japan

Speaker(s)

Yoshifumi  Ukyo

Yoshifumi Ukyo

  • Manager, Statistics & Decision Sciences
  • Janssen Pharmaceutical K.K., Japan
Junichi  Asano, PhD

Junichi Asano, PhD

  • Statistical Reviewer
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Shogo  Nomura, PhD

Shogo Nomura, PhD

  • Statistician, Department of Biostatistics
  • The University of Tokyo, Japan